CT-400P

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCT-400P
Drug Alias NameFGF-1 ligand (CisThera)fibroblast growth factor antagonist (CisThera)PEGylated CT-400 (CisThera)CT-400P
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonistsFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsBone metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCisThera Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCisThera Inc
Active IndicationsN/A
Inactive IndicationsBone metastases

Other Information

ATC CodeN/A
Related LinksN/A